Company: MDCXW
Filing Date: 2025-10-17
Form Type: 424B3
Source: 0001062993-25-016188
Chunk: 4

Company: Medicus Pharma Ltd.
Filing Date: 2025-10-17
Form: 424B3
Chunk 4
---
claims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Readers are cautioned that the foregoing list is not exhaustive, and readers are encouraged to review the Company's annual report on Form 10-K on the Company's profile on EDGAR at www.sec.govand on SEDAR+ at www.sedarplus.caand the Company’s other public filings on EDGAR and on SEDAR+. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

​

| MEDICUS PHARMA LTD. |                                                |
| By:                 | /s/ Raza Bokhari                               |
| Name:               | Dr. Raza Bokhari                               |
| Title:              | Executive Chairman and Chief Executive Officer |

​

Dated: October 17, 2025​